NEU 2.81% $18.65 neuren pharmaceuticals limited

TBI: Trials and Tribulations, page-2

  1. 2,148 Posts.
    lightbulb Created with Sketch. 40
    One would have to be very optimistic about our chances of a positive outcome considering the amount of research and money poured into TBI therapies. A huge market to tap into but obviously a very difficult type of condition to find adequate and effective treatments for. Considering recent outcomes a negative on TBI would absolutely kill NEU share price.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.